MPD: Measures involving CC

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Bennett4:1	Bennett4	None	(none)	coat color coat 114695 categorical informational HP HFHS	CC	22	f		N=5	2021

Bennett4:3	Bennett4	None	(none)	age_wks age_wks 114697 informational HP HFHS	CC	22	f		N=5	2021

Bennett4:5	Bennett4	None	(none)	batch batch 114699 informational HP HFHS	CC	22	f		N=5	2021

Bennett4:7	Bennett4	body weight	various diets 2	body weight, baseline [g] bw_base 114701 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:9	Bennett4	body weight	various diets 2	body weight, post-diet [g] bw_post 114703 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:11	Bennett4	MRI	various diets 2	fat mass, baseline [g] fat_base 114705 diet: HP group HFHS group	CC	22	f	8-10wks	N=5	2021

Bennett4:13	Bennett4	MRI	various diets 2	fat mass, post-diet [g] fat_post 114707 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:15	Bennett4	MRI	various diets 2	percentage of body weight that is fat, baseline [%] fat_pct_base 114709 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:17	Bennett4	MRI	various diets 2	percentage of body weight that is fat, post-diet [%] fat_pct_post 114711 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:19	Bennett4	MRI	various diets 2	lean mass, baseline [g] lean_base 114713 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:21	Bennett4	MRI	various diets 2	lean mass, post-diet [g] lean_post 114715 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:23	Bennett4	MRI	various diets 2	percentage of body weight that is lean, baseline [%] lean_pct_base 114717 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:25	Bennett4	MRI	various diets 2	percentage of body weight that is lean, post-diet [%] lean_pct_post 114719 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:27	Bennett4	MRI	various diets 2	free water mass, baseline [g] water_free_base 114721 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:29	Bennett4	MRI	various diets 2	free water mass, post-diet [g] water_free_post 114723 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:31	Bennett4	MRI	various diets 2	total water mass, baseline [g] water_tot_base 114725 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:33	Bennett4	MRI	various diets 2	total water mass, post-diet [g] water_tot_post 114727 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:35	Bennett4	metabolic panel	various diets 2	plasma albumin amount, baseline [g/L] ALB_base 114729 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:37	Bennett4	metabolic panel	various diets 2	plasma albumin amount, post-diet [g/L] ALB_post 114731 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:39	Bennett4	metabolic panel	various diets 2	plasma alanine aminotransferase (ALT) amount, baseline [U/L] ALT_base 114733 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:41	Bennett4	metabolic panel	various diets 2	plasma alanine aminotransferase (ALT) amount, post-diet [U/L] ALT_post 114735 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:43	Bennett4	metabolic panel	various diets 2	plasma aspartate aminotransferase (AST) amount, baseline [U/L] AST_base 114737 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:45	Bennett4	metabolic panel	various diets 2	plasma aspartate aminotransferase (AST) amount, post-diet [U/L] AST_post 114739 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:47	Bennett4	metabolic panel	various diets 2	plasma creatinine amount, baseline [µmol/L] CRE_base 114741 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:49	Bennett4	metabolic panel	various diets 2	plasma creatinine amount, post-diet [µmol/L] CRE_post 114743 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:51	Bennett4	metabolic panel	various diets 2	plasma glucose amount, baseline [mg/dL] GLU_base 114745 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:53	Bennett4	metabolic panel	various diets 2	plasma glucose amount, post-diet [mg/dL] GLU_post 114747 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:55	Bennett4	metabolic panel	various diets 2	plasma urea/BUN amount, baseline [mmol/L] UREA_base 114749 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:57	Bennett4	metabolic panel	various diets 2	plasma urea/BUN amount, post-diet [mmol/L] UREA_post 114751 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:59	Bennett4	lipid profile	various diets 2	plasma cholesterol amount, baseline [mg/dL] CHOL_base 114753 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:61	Bennett4	lipid profile	various diets 2	plasma cholesterol amount, post-diet [mg/dL] CHOL_post 114755 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:63	Bennett4	lipid profile	various diets 2	plasma nonesterified fatty acid amount, baseline [mEq/L] NEFA_base 114757 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:65	Bennett4	lipid profile	various diets 2	plasma nonesterified fatty acid amount, post-diet [mEq/L] NEFA_post 114759 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:67	Bennett4	lipid profile	various diets 2	plasma triglyceride amount, baseline [mg/dL] TG_base 114761 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:69	Bennett4	lipid profile	various diets 2	plasma triglyceride amount, post-diet [mg/dL] TG_post 114763 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:71	Bennett4	biomarker quantification	various diets 2	plasma trimethylamine N-oxide (TMAO) amount, baseline [µM] TMAO_base 114765 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:73	Bennett4	biomarker quantification	various diets 2	plasma trimethylamine N-oxide (TMAO) amount, post-diet [µM] TMAO_post 114767 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:75	Bennett4	biomarker quantification	various diets 2	plasma choline amount, baseline [µM] CHO_base 114769 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:77	Bennett4	biomarker quantification	various diets 2	plasma choline amount, post-diet [µM] CHO_post 114771 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:79	Bennett4	biomarker quantification	various diets 2	plasma betaine amount, baseline [µM] BET_base 114773 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:81	Bennett4	biomarker quantification	various diets 2	plasma betaine amount, post-diet [µM] BET_post 114775 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:83	Bennett4	biomarker quantification	various diets 2	plasma phosphocholine amount, baseline [µM] PC_base 114777 diet: HP group HFHS group	CC	22	f	8-11wks	N=4	2021

Bennett4:85	Bennett4	biomarker quantification	various diets 2	plasma phosphocholine amount, post-diet [µM] PC_post 114779 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:87	Bennett4	biomarker quantification	various diets 2	plasma carnitine amount, baseline [µM] CARN_base 114781 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:89	Bennett4	biomarker quantification	various diets 2	plasma carnitine amount, post-diet [µM] CARN_post 114783 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:91	Bennett4	biomarker quantification	various diets 2	plasma glycerophosphocholine amount, post-diet [µM] GPC_post 114785 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:93	Bennett4	hormone quantification	various diets 2	plasma insulin amount, baseline [ng/mL] INS_base 114787 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:95	Bennett4	hormone quantification	various diets 2	plasma insulin amount, post-diet [ng/mL] INS_post 114789 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:97	Bennett4	hormone quantification	various diets 2	plasma glucose to insulin ratio, baseline [ratio] GLU_INS_base 114791 diet: HP group HFHS group	CC	22	f	8-11wks	N=5	2021

Bennett4:99	Bennett4	hormone quantification	various diets 2	plasma glucose to insulin ratio, post-diet [ratio] GLU_INS_post 114793 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:101	Bennett4	metabolic panel	various diets 2	metabolic health score, baseline [score] health_base 114795 diet: HP group HFHS group	CC	22	f	8-11wks	N=4	2021

Bennett4:103	Bennett4	metabolic panel	various diets 2	metabolic health score, post-diet [score] health_post 114797 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:105	Bennett4	monitoring system	various diets 2	oxygen consumption accounting for body weight, day [mL/kg/h] VO2_bw_day 114799 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:107	Bennett4	monitoring system	various diets 2	oxygen consumption accounting for body weight, night [mL/kg/h] VO2_bw_night 114801 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:109	Bennett4	monitoring system	various diets 2	oxygen consumption accounting for body weight, average for day and night [mL/kg/h] VO2_bw_ave 114803 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:111	Bennett4	monitoring system	various diets 2	oxygen consumption accounting for lean mass, day [mL/kg/h] VO2_lean_day 114805 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:113	Bennett4	monitoring system	various diets 2	oxygen consumption accounting for lean mass, night [mL/kg/h] VO2_lean_night 114807 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:115	Bennett4	monitoring system	various diets 2	oxygen consumption accounting for lean mass, average for day and night [mL/kg/h] VO2_lean_ave 114809 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:117	Bennett4	monitoring system	various diets 2	oxygen consumption, day [mL/h] VO2_day 114811 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:119	Bennett4	monitoring system	various diets 2	oxygen consumption, night [mL/h] VO2_night 114813 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:121	Bennett4	monitoring system	various diets 2	oxygen consumption, average for day and night [mL/h] VO2_ave 114815 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:123	Bennett4	monitoring system	various diets 2	carbon dioxide production accounting for body weight, day [mL/kg/h] VCO2_bw_day 114817 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:125	Bennett4	monitoring system	various diets 2	carbon dioxide production accounting for body weight, night [mL/kg/h] VCO2_bw_night 114819 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:127	Bennett4	monitoring system	various diets 2	carbon dioxide production accounting for body weight, average for day and night [mL/kg/h] VCO2_bw_ave 114821 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:129	Bennett4	monitoring system	various diets 2	carbon dioxide production accounting for lean mass, day [mL/kg/h] VCO2_lean_day 114823 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:131	Bennett4	monitoring system	various diets 2	carbon dioxide production accounting for lean mass, night [mL/kg/h] VCO2_lean_night 114825 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:133	Bennett4	monitoring system	various diets 2	carbon dioxide production accounting for lean mass, average for day and night [mL/kg/h] VCO2_lean_ave 114827 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:135	Bennett4	monitoring system	various diets 2	carbon dioxide production, day [mL/h] VCO2_day 114829 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:137	Bennett4	monitoring system	various diets 2	carbon dioxide production, night [mL/h] VCO2_night 114831 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:139	Bennett4	monitoring system	various diets 2	carbon dioxide production, average for day and night [mL/h] VCO2_ave 114833 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:141	Bennett4	monitoring system	various diets 2	respiratory exchange ratio (VCO2/O2), day [ratio] RER_day 114835 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:143	Bennett4	monitoring system	various diets 2	respiratory exchange ratio (VCO2/O2), night [ratio] RER_night 114837 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:145	Bennett4	monitoring system	various diets 2	respiratory exchange ratio (VCO2/O2), average for day and night [ratio] RER_ave 114839 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:147	Bennett4	monitoring system	various diets 2	heat expenditure accounting for body weight, day [kcal/h/kg] heat_bw_day 114841 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:149	Bennett4	monitoring system	various diets 2	heat expenditure accounting for body weight, night [kcal/h/kg] heat_bw_night 114843 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:151	Bennett4	monitoring system	various diets 2	heat expenditure accounting for body weight, average for day and night [kcal/h/kg] heat_bw_ave 114845 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:153	Bennett4	monitoring system	various diets 2	heat expenditure accounting for lean mass, day [kcal/h/kg] heat_lean_day 114847 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:155	Bennett4	monitoring system	various diets 2	heat expenditure accounting for lean mass, night [kcal/h/kg] heat_lean_night 114849 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:157	Bennett4	monitoring system	various diets 2	heat expenditure accounting for lean mass, average for day and night [kcal/h/kg] heat_lean_ave 114851 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:159	Bennett4	monitoring system	various diets 2	heat expenditure, day [kcal/h] heat_day 114853 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:161	Bennett4	monitoring system	various diets 2	heat expenditure, night [kcal/h] heat_night 114855 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:163	Bennett4	monitoring system	various diets 2	heat expenditure, average for day and night [kcal/h] heat_ave 114857 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:165	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis (beam breaks), day [n] XY_day 114859 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:167	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis (beam breaks), night [n] XY_night 114861 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:169	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis (beam breaks), average for day and night [n] XY_ave 114863 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:171	Bennett4	monitoring system	various diets 2	activity on x-axis total (beam breaks), day [n] X_day 114865 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:173	Bennett4	monitoring system	various diets 2	activity on x-axis total (beam breaks), night [n] X_night 114867 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:175	Bennett4	monitoring system	various diets 2	activity on x-axis total (beam breaks), average for day and night [n] X_ave 114869 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:177	Bennett4	monitoring system	various diets 2	activity on x-axis ambulatory movement (beam breaks), day [n] X_amb_day 114871 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:179	Bennett4	monitoring system	various diets 2	activity on x-axis ambulatory movement (beam breaks), night [n] X_amb_night 114873 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:181	Bennett4	monitoring system	various diets 2	activity on x-axis ambulatory movement (beam breaks), average for day and night [n] X_amb_ave 114875 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:183	Bennett4	monitoring system	various diets 2	activity on x-axis fine movement (beam breaks), day [n] X_fine_day 114877 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:185	Bennett4	monitoring system	various diets 2	activity on x-axis fine movement (beam breaks), night [n] X_fine_night 114879 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:187	Bennett4	monitoring system	various diets 2	activity on x-axis fine movement (beam breaks), average for day and night [n] X_fine_ave 114881 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:189	Bennett4	monitoring system	various diets 2	activity on y-axis total (beam breaks), day [n] Y_day 114883 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:191	Bennett4	monitoring system	various diets 2	activity on y-axis total (beam breaks), night [n] Y_night 114885 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:193	Bennett4	monitoring system	various diets 2	activity on y-axis total (beam breaks), average for day and night [n] Y_ave 114887 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:195	Bennett4	monitoring system	various diets 2	activity on y-axis ambulatory movement (beam breaks), day [n] Y_amb_day 114889 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:197	Bennett4	monitoring system	various diets 2	activity on y-axis ambulatory movement (beam breaks), night [n] Y_amb_night 114891 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:199	Bennett4	monitoring system	various diets 2	activity on y-axis ambulatory movement (beam breaks), average for day and night [n] Y_amb_ave 114893 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:201	Bennett4	monitoring system	various diets 2	activity on y-axis fine movement (beam breaks), day [n] Y_fine_day 114895 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:203	Bennett4	monitoring system	various diets 2	activity on y-axis fine movement (beam breaks), night [n] Y_fine_night 114897 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:205	Bennett4	monitoring system	various diets 2	activity on y-axis fine movement (beam breaks), average for day and night [n] Y_fine_ave 114899 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:207	Bennett4	monitoring system	various diets 2	activity on z-axis rearing movement (beam breaks), day [n] Z_day 114901 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:209	Bennett4	monitoring system	various diets 2	activity on z-axis rearing movement (beam breaks), night [n] Z_night 114903 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:211	Bennett4	monitoring system	various diets 2	activity on z-axis rearing movement (beam breaks), average for day and night [n] Z_ave 114905 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:213	Bennett4	intake monitoring	various diets 2	feed consumed, day [g] feed_day 114907 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:215	Bennett4	intake monitoring	various diets 2	feed consumed, night [g] feed_night 114909 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:217	Bennett4	intake monitoring	various diets 2	feed consumed, average for day and night [g] feed_ave 114911 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:219	Bennett4	intake monitoring	various diets 2	energy intake, day [kcal] energy_day 114913 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:221	Bennett4	intake monitoring	various diets 2	energy intake, night [kcal] energy_night 114915 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:223	Bennett4	intake monitoring	various diets 2	energy intake, average for day and night [kcal] energy_ave 114917 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:225	Bennett4	intake monitoring	various diets 2	protein intake, day [g] prot_day 114919 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:227	Bennett4	intake monitoring	various diets 2	protein intake, night [g] prot_night 114921 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:229	Bennett4	intake monitoring	various diets 2	protein intake, average for day and night [g] prot_ave 114923 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:231	Bennett4	intake monitoring	various diets 2	fat intake, day [g] fat_day 114925 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:233	Bennett4	intake monitoring	various diets 2	fat intake, night [g] fat_night 114927 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:235	Bennett4	intake monitoring	various diets 2	fat intake, average for day and night [g] fat_ave 114929 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:237	Bennett4	intake monitoring	various diets 2	carbohydrate intake, day [g] carb_day 114931 diet: HP group HFHS group:	CC	22	f	17-20wks	N=4	2021

Bennett4:239	Bennett4	intake monitoring	various diets 2	carbohydrate intake, night [g] carb_night 114933 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:241	Bennett4	intake monitoring	various diets 2	carbohydrate intake, average for day and night [g] carb_ave 114935 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:243	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis plus z-axis (beam breaks), day [n] XYZ_day 114937 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:245	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis plus z-axis (beam breaks), night [n] XYZ_night 114939 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:247	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis plus z-axis (beam breaks), average for day and night [n] XYZ_ave 114941 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:249	Bennett4	intake monitoring	various diets 2	feed consumed per hour, day [g/h] feed_hr_day 114943 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:251	Bennett4	intake monitoring	various diets 2	feed consumed per hour, night [g/h] feed_hr_night 114945 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:253	Bennett4	intake monitoring	various diets 2	feed consumed per hour, average for day and night [g/h] feed_hr_ave 114947 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:255	Bennett4	intake monitoring	various diets 2	energy intake per hour, day [kcal/h] energy_hr_day 114949 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:257	Bennett4	intake monitoring	various diets 2	energy intake per hour, night [kcal/h] energy_hr_night 114951 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:259	Bennett4	intake monitoring	various diets 2	energy intake per hour, average for day and night [kcal/h] energy_hr_ave 114953 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:261	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis plus z-axis (beam breaks) per hour, day [n/h] XYZ_hr_day 114955 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:263	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis plus z-axis (beam breaks) per hour, night [n/h] XYZ_hr_night 114957 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Bennett4:265	Bennett4	monitoring system	various diets 2	activity on x-axis plus y-axis plus z-axis (beam breaks) per hour, average for day and night [n/h] XYZ_hr_ave 114959 diet: HP group HFHS group	CC	22	f	17-20wks	N=4	2021

Brinkmeyer1:1	Brinkmeyer1	body weight	Theiler's murine encephalomyelitis virus	body weight, post infection [g] bw 64401 day 0 day 2 day 4 day 6 day 8 day 10 day 14 day 17 day 22 day 27 (6 more)...	CC	5	both	4wks	N=5	2017

Brinkmeyer1:17	Brinkmeyer1	health assessment	Theiler's murine encephalomyelitis virus	clinical score (0=normal, 6=moribund), post infection [score] clin_score 64417 day 0 day 2 day 4 day 6 day 8 day 12 day 18 day 24 day 29 day 34 (6 more)...	CC	5	both	4wks	N=5	2017

Brinkmeyer1:33	Brinkmeyer1	RNA expression profiling	Theiler's murine encephalomyelitis virus	TMEV transcript abundance (normalized), post infection TMEV 64433 day 7 day 28	CC	4	both	4wks	N=1	2017

Brinkmeyer1:35	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of seconds spent grooming, 10 min test, post infection wk 3 (manual assessment) [s] grooming 64435	CC	5	both	4wks	N=2	2017

Brinkmeyer1:36	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of times mouse reared, 10 min test, post infection wk 3 (manual assessment) [n] activity_rearing 64436	CC	5	both	4wks	N=2	2017

Brinkmeyer1:37	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	horizontal movement latency, 30 min test, post infection wk 3 [s] horiz_latency 64437 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:39	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of horizontal movements (beam breaks), 30 min test, post infection wk 3 [n] horiz_activity 64439 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:41	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	horizontal distance traveled, 30 min test, post infection wk 3 [cm] horiz_distance 64441 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:43	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent moving horizontally, 30 min test, post infection wk 3 [s] horiz_time 64443 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:45	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	horizontal movement velocity, 30 min test, post infection wk 3 [cm/s] horiz_velocity 64445 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:47	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of vertical plane entries, 30 min test, post infection wk 3 [n] vert_activity 64447 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:49	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of vertical plane episodes, 30 min test, post infection wk 3 [n] vert_episodes 64449 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:51	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent vertical, 30 min test, post infection wk 3 [s] vert_time 64451 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:53	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent resting, 30 min test, post infection wk 3 [s] resting 64453 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:55	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	number of center entries, 30 min test, post infection wk 3 [n] center_entries 64455 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:57	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent in center, 30 min test, post infection wk 3 [s] center_time 64457 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:59	Brinkmeyer1	open field test	Theiler's murine encephalomyelitis virus	time spent in periphery, 30 min test, post infection wk 3 [s] periphery_time 64459 trial 1 trial 2	CC	4	both	4wks	N=2	2017

Brinkmeyer1:61	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	number of steps included in analysis as measured by DigiGait, post infection day 27, forelimb [n] num_steps_fore 64461 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:63	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	number of steps included in analysis as measured by DigiGait, post infection day 27, hindlimb [n] num_steps_hind 64463 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:65	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of swing phase (no paw contact with belt) as measured by DigiGait, post infection day 27, forelimb [s] swing_dur_fore 64465 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:67	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of swing phase (no paw contact with belt) as measured by DigiGait, post infection day 27, hindlimb [s] swing_dur_hind 64467 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:69	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in air as measured by DigiGait, post infection day 27, forelimb [%] swing_stride_fore 64469 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:71	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in air as measured by DigiGait, post infection day 27, hindlimb [%] swing_stride_hind 64471 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:73	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of braking phase as measured by DigiGait, post infection day 27, forelimb [s] brake_dur_fore 64473 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:75	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of braking phase as measured by DigiGait, post infection day 27, hindlimb [s] brake_dur_hind 64475 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:77	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in braking phase as measured by DigiGait, post infection day 27, forelimb [%] brake_stride_fore 64477 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:79	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in braking phase as measured by DigiGait, post infection day 27, hindlimb [%] brake_stride_hind 64479 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:81	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of stance phase that paw is in braking phase as measured by DigiGait, post infection day 27, forelimb [%] brake_stance_fore 64481 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:83	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of stance phase that paw is in braking phase as measured by DigiGait, post infection day 27, hindlimb [%] brake_stance_hind 64483 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:85	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of propulsion phase as measured by DigiGait, post infection day 27, forelimb [s] propel_dur_fore 64485 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:87	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of propulsion phase as measured by DigiGait, post infection day 27, hindlimb [s] propel_dur_hind 64487 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:89	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in propulsion phase as measured by DigiGait, post infection day 27, forelimb [%] propel_stride_fore 64489 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:91	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in propulsion phase as measured by DigiGait, post infection day 27, hindlimb [%] propel_stride_hind 64491 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:93	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of stance phase that paw is in propulsion phase as measured by DigiGait, post infection day 27, forelimb [%] propel_stance_fore 64493 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:95	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of stance phase that paw is in propulsion phase as measured by DigiGait, post infection day 27, hindlimb [%] propel_stance_hind 64495 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:97	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in any contact with treadmill belt as measured by DigiGait, post infection day 27, forelimb [%] stance_stride_fore 64497 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:99	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	percentage of total stride duration that paw is in any contact with treadmill belt as measured by DigiGait, post infection day 27, hindlimb [%] stance_stride_hind 64499 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:101	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of swing phase time to stance phase time as measured by DigiGait, post infection day 27, forelimb [ratio] stance_swing_fore 64501 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:103	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of swing phase time to stance phase time as measured by DigiGait, post infection day 27, hindlimb [ratio] stance_swing_hind 64503 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:105	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of one complete stride for one paw (equal to stance and swing durations) as measured by DigiGait, post infection day 27, forelimb [s] stride_dur_fore 64505 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:107	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	duration of one complete stride for one paw (equal to stance and swing durations) as measured by DigiGait, post infection day 27, hindlimb [s] stride_dur_hind 64507 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:109	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	number of times each second (cadence) that a paw takes a complete stride as measured by DigiGait, post infection day 27, forelimb [n/s] stride_freq_fore 64509 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:111	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	number of times each second (cadence) that a paw takes a complete stride as measured by DigiGait, post infection day 27, hindlimb [n/s] stride_freq_hind 64511 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:113	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	spatial length that a paw traverses through a given stride as measured by DigiGait, post infection day 27, forelimb [cm] stride_length_fore 64513 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:115	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	spatial length that a paw traverses through a given stride as measured by DigiGait, post infection day 27, hindlimb [cm] stride_length_hind 64515 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:117	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride length variability as measured by DigiGait, post infection day 27, forelimb [cm] stride_length_var_fore 64517 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:119	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride length variability as measured by DigiGait, post infection day 27, hindlimb [cm] stride_length_var_hind 64519 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:121	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride length coefficient of variation as measured by DigiGait, post infection day 27, forelimb [%] stride_length_CV_fore 64521 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:123	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride length coefficient of variation as measured by DigiGait, post infection day 27, hindlimb [%] stride_length_CV_hind 64523 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:125	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	angle that paw makes with long axis of direction of motion of mouse as measured by DigiGait, post infection day 27, forelimb [deg] paw_angle_fore 64525 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:127	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	angle that paw makes with long axis of direction of motion of mouse as measured by DigiGait, post infection day 27, hindlimb [deg] paw_angle_hind 64527 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:129	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	standard deviation of paw angle for set of strides recorded as measured by DigiGait, post infection day 27, forelimb [deg] paw_angle_SD_fore 64529 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:131	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	standard deviation of paw angle for set of strides recorded as measured by DigiGait, post infection day 27, hindlimb [deg] paw_angle_SD_hind 64531 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:133	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal paw area as measured by DigiGait, post infection day 27, forelimb [cm²] paw_area_max_fore 64533 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:135	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal paw area as measured by DigiGait, post infection day 27, hindlimb [cm²] paw_area_max_hind 64535 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:137	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	standard deviation of paw area for set of strides recorded as measured by DigiGait, post infection day 27, forelimb [cm²] paw_area_SD_fore 64537 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:139	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	standard deviation of paw area for set of strides recorded as measured by DigiGait, post infection day 27, hindlimb [cm²] paw_area_SD_hind 64539 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:141	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of forelimb stepping to fore limb stepping frequency (coordination metric) as measured by DigiGait, post infection day 27, forelimb [ratio] gait_symmetry_fore 64541 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:143	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of forelimb stepping to hind limb stepping frequency (coordination metric) as measured by DigiGait, post infection day 27, hindlimb [ratio] gait_symmetry_hind 64543 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:145	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_break_fore 64545 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:147	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_break_hind 64547 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:149	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_propuls_fore 64549 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:151	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_propuls_hind 64551 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:153	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	overlap extent of ipsilateral fore and hind paws as measured by DigiGait, post infection day 27, forelimb [cm] overlap_distance_fore 64553 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:155	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	overlap extent of ipsilateral fore and hind paws as measured by DigiGait, post infection day 27, hindlimb [cm] overlap_distance_hind 64555 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:157	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	extent of overlap between ipsilateral fore and hind paws during full stance (balance metric) as measured by DigiGait, post infection day 27, forelimb [cm] paw_placement_fore 64557 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:159	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	extent of overlap between ipsilateral fore and hind paws during full stance (balance metric) as measured by DigiGait, post infection day 27, hindlimb [cm] paw_placement_hind 64559 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:161	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	gait variability metric as measured by DigiGait, post infection day 27, forelimb ataxia_coefficient_fore 64561 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:163	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	gait variability metric as measured by DigiGait, post infection day 27, hindlimb ataxia_coefficient_hind 64563 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:165	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	distance between centroid of a paw at peak stance and a reference line drawn through transverse midline of mouse (kinetics metric) as measured by DigiGait, post infection day 27, forelimb [cm] midline_distance_fore 64565 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:167	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	distance between centroid of a paw at peak stance and a reference line drawn through transverse midline of mouse (kinetics metric) as measured by DigiGait, post infection day 27, hindlimb [cm] midline_distance_hind 64567 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:169	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	distance between centroid of a paw at peak stance and a reference line drawn through axis of mouse (kinetics metric) as measured by DigiGait, post infection day 27, forelimb [cm] axis_distance_fore 64569 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:171	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	distance between centroid of a paw at peak stance and a reference line drawn through axis of mouse (kinetics metric) as measured by DigiGait, post infection day 27, hindlimb [cm] axis_distance_hind 64571 left right	CC	4	both	4wks	N=1	2017

Brinkmeyer1:173	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	perpendicular distance between centroids of either set of axial paws during peak stance as measured by DigiGait, post infection day 27 [cm] stance_width 64573 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:175	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stance width coefficient of variation as measured by DigiGait, post infection day 27 [%] stance_width_CV 64575 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:177	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	ratio of left and right stance durations as measured by DigiGait, post infection day 27 [ratio] stance_factor 64577 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:179	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	stride width variability as measured by DigiGait, post infection day 27 [cm] stride_width_var 64579 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:181	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	angle made between left and right paws as a function of stride length and stance width as measured by DigiGait, post infection day 27 [deg] step_angle 64581 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:183	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	step angle variability (standard deviation of step angle for set of strides recorded) as measured by DigiGait, post infection day 27 [deg] step_angle_SD 64583 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:185	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	step angle coefficient of variation as measured by DigiGait, post infection day 27 [%] step_angle_CV 64585 forelimb hindlimb	CC	4	both	4wks	N=1	2017

Brinkmeyer1:187	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	length of forelimb steps as measured by foot print analysis, post infection [cm] length_fore 64587 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:194	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	width of forelimb steps as measured by foot print analysis, post infection [cm] width_fore 64594 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:201	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	length of hindlimb steps as measured by foot print analysis, post infection [cm] length_hind 64601 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:208	Brinkmeyer1	gait analysis	Theiler's murine encephalomyelitis virus	width of hindlimb steps as measured by foot print analysis, post infection [cm] width_hind 64608 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13	CC	5	both	4wks	N=2	2017

Brinkmeyer1:215	Brinkmeyer1	rotarod	Theiler's murine encephalomyelitis virus	time to fall from accelerating rotarod, post infection wk 7 [s] rotarod 64615 trial 1 trial 2 trial 3 trial 4 trial 5 trial 6 trial 7 trial 8 trial 9	CC	5	both	4wks	N=2	2017

CSNA03:2	CSNA03	open field test	(none)	total distance traveled, 60 min test (OFT), CC [cm] dist_OFT_cc 90002	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:5	CSNA03	open field test	(none)	distance traveled in perimeter and corners, 60 min test (OFT), CC [cm] dist_perimeter_corners_OFT_cc 90005	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:8	CSNA03	open field test	(none)	distance traveled in perimeter, 60 min test (OFT), CC [cm] dist_perimeter_OFT_cc 90008	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:11	CSNA03	open field test	(none)	distance traveled in corners, 60 min test (OFT), CC [cm] dist_corners_OFT_cc 90011	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:14	CSNA03	open field test	(none)	percentage of total distance traveled in center, 60 min test (OFT), CC [%] pct_dist_center_OFT_cc 90014	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:17	CSNA03	open field test	(none)	distance traveled slope, 60 min test (OFT), CC dist_slope_OFT_cc 90017	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:31	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:56	CSNA03	open field test	(none)	habituation ratio (first:last intervals), 60 min test (OFT), CC [ratio] habituation_OFT_cc 90056	CC w/par	59	both	4-19wks	N=15	2018

CSNA03:101	CSNA03	open field test	(none)	time in perimeter and corners, 60 min test (OFT), CC [s] time_perimeter_corners_OFT_cc 90101	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:104	CSNA03	open field test	(none)	time in perimeter, 60 min test (OFT), CC [s] time_perimeter_OFT_cc 90104	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:107	CSNA03	open field test	(none)	time in corners, 60 min test (OFT), CC [s] time_corner_OFT_cc 90107	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:110	CSNA03	open field test	(none)	percentage of total time spent in center, 60 min test (OFT), CC [%] pct_center_time_OFT_cc 90110	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:113	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter and corners, 60 min test (OFT), CC [%] pct_dist_perimeter_corners_OFT_cc 90113	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:116	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter, 60 min test (OFT), CC [%] pct_dist_perimeter_OFT_cc 90116	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:119	CSNA03	open field test	(none)	percentage of total time spent in perimeter and corners, 60 min test (OFT), CC [%] pct_time_perimeter_corner_OFT_cc 90119	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:122	CSNA03	open field test	(none)	percentage of total time spent in perimeter, 60 min test (OFT), CC [%] pct_time_perimeter_OFT_cc 90122	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:125	CSNA03	open field test	(none)	time in center, 60 min test (OFT), CC [s] center_time_OFT_cc 90125	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:128	CSNA03	open field test	(none)	distance traveled in center, 60 min test (OFT), CC [cm] center_dist_OFT_cc 90128	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:131	CSNA03	light-dark box	(none)	total distance traveled, 20 min test (LD box), CC [cm] dist_LD_cc 90131	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:134	CSNA03	light-dark box	(none)	distance traveled in light, 20 min test (LD box), CC [cm] dist_light_LD_cc 90134	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:137	CSNA03	light-dark box	(none)	distance traveled in dark, 20 min test (LD box), CC [cm] dist_dark_LD_cc 90137	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:140	CSNA03	light-dark box	(none)	percentage of total distance traveled in light, 20 min test (LD box), CC [%] pct_dist_light_LD_cc 90140	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:143	CSNA03	light-dark box	(none)	total ambulatory time, 20 min test (LD box), CC [s] amb_time_tot_LD_cc 90143	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:146	CSNA03	light-dark box	(none)	ambulatory time in light, 20 min test (LD box), CC [s] amb_time_light_LD_cc 90146	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:149	CSNA03	light-dark box	(none)	ambulatory time in dark, 20 min test (LD box), CC [s] amb_time_dark_LD_cc 90149	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:152	CSNA03	light-dark box	(none)	percentage of time spent ambulatory in light, 20 min test (LD box), CC [%] pct_amb_time_light_LD_cc 90152	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:164	CSNA03	light-dark box	(none)	percentage of time resting in light, 20 min test (LD box), CC [%] pct_rest_time_light_LD_cc 90164	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:203	CSNA03	light-dark box	(none)	total time, 20 min test (LD box), CC [s] time_tot_LD_cc 90203	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:206	CSNA03	light-dark box	(none)	time in light, 20 min test (LD box), CC [s] time_light_LD_cc 90206	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:209	CSNA03	light-dark box	(none)	time in dark, 20 min test (LD box), CC [s] time_dark_LD_cc 90209	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:212	CSNA03	light-dark box	(none)	percentage of time in light, 20 min test (LD box), CC [%] pct_time_light_LD_cc 90212	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:215	CSNA03	light-dark box	(none)	total ambulatory counts, 20 min test (LD box), CC [n] amb_counts_tot_LD_cc 90215	CC w/par	59	both	4-19wks	N=18	2018

Bennett4

None

(none)

coat color coat 114695 categorical informational HP HFHS

CC

22

f

N=5

2021

Bennett4

None

(none)

age_wks age_wks 114697 informational HP HFHS

CC

22

f

N=5

2021

Bennett4

None

(none)

batch batch 114699 informational HP HFHS

CC

22

f

N=5

2021

Bennett4

body weight

various diets 2

body weight, baseline [g] bw_base 114701 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

body weight

various diets 2

body weight, post-diet [g] bw_post 114703 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

MRI

various diets 2

fat mass, baseline [g] fat_base 114705 diet: HP group HFHS group

CC

22

f

8-10wks

N=5

2021

Bennett4

MRI

various diets 2

fat mass, post-diet [g] fat_post 114707 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

MRI

various diets 2

percentage of body weight that is fat, baseline [%] fat_pct_base 114709 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

MRI

various diets 2

percentage of body weight that is fat, post-diet [%] fat_pct_post 114711 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

MRI

various diets 2

lean mass, baseline [g] lean_base 114713 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

MRI

various diets 2

lean mass, post-diet [g] lean_post 114715 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

MRI

various diets 2

percentage of body weight that is lean, baseline [%] lean_pct_base 114717 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

MRI

various diets 2

percentage of body weight that is lean, post-diet [%] lean_pct_post 114719 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

MRI

various diets 2

free water mass, baseline [g] water_free_base 114721 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

MRI

various diets 2

free water mass, post-diet [g] water_free_post 114723 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

MRI

various diets 2

total water mass, baseline [g] water_tot_base 114725 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

MRI

various diets 2

total water mass, post-diet [g] water_tot_post 114727 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

metabolic panel

various diets 2

plasma albumin amount, baseline [g/L] ALB_base 114729 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

metabolic panel

various diets 2

plasma albumin amount, post-diet [g/L] ALB_post 114731 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

metabolic panel

various diets 2

plasma alanine aminotransferase (ALT) amount, baseline [U/L] ALT_base 114733 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

metabolic panel

various diets 2

plasma alanine aminotransferase (ALT) amount, post-diet [U/L] ALT_post 114735 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

metabolic panel

various diets 2

plasma aspartate aminotransferase (AST) amount, baseline [U/L] AST_base 114737 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

metabolic panel

various diets 2

plasma aspartate aminotransferase (AST) amount, post-diet [U/L] AST_post 114739 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

metabolic panel

various diets 2

plasma creatinine amount, baseline [µmol/L] CRE_base 114741 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

metabolic panel

various diets 2

plasma creatinine amount, post-diet [µmol/L] CRE_post 114743 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

metabolic panel

various diets 2

plasma glucose amount, baseline [mg/dL] GLU_base 114745 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

metabolic panel

various diets 2

plasma glucose amount, post-diet [mg/dL] GLU_post 114747 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

metabolic panel

various diets 2

plasma urea/BUN amount, baseline [mmol/L] UREA_base 114749 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

metabolic panel

various diets 2

plasma urea/BUN amount, post-diet [mmol/L] UREA_post 114751 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

lipid profile

various diets 2

plasma cholesterol amount, baseline [mg/dL] CHOL_base 114753 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

lipid profile

various diets 2

plasma cholesterol amount, post-diet [mg/dL] CHOL_post 114755 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

lipid profile

various diets 2

plasma nonesterified fatty acid amount, baseline [mEq/L] NEFA_base 114757 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

lipid profile

various diets 2

plasma nonesterified fatty acid amount, post-diet [mEq/L] NEFA_post 114759 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

lipid profile

various diets 2

plasma triglyceride amount, baseline [mg/dL] TG_base 114761 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

lipid profile

various diets 2

plasma triglyceride amount, post-diet [mg/dL] TG_post 114763 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

biomarker quantification

various diets 2

plasma trimethylamine N-oxide (TMAO) amount, baseline [µM] TMAO_base 114765 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

biomarker quantification

various diets 2

plasma trimethylamine N-oxide (TMAO) amount, post-diet [µM] TMAO_post 114767 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

biomarker quantification

various diets 2

plasma choline amount, baseline [µM] CHO_base 114769 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

biomarker quantification

various diets 2

plasma choline amount, post-diet [µM] CHO_post 114771 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

biomarker quantification

various diets 2

plasma betaine amount, baseline [µM] BET_base 114773 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

biomarker quantification

various diets 2

plasma betaine amount, post-diet [µM] BET_post 114775 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

biomarker quantification

various diets 2

plasma phosphocholine amount, baseline [µM] PC_base 114777 diet: HP group HFHS group

CC

22

f

8-11wks

N=4

2021

Bennett4

biomarker quantification

various diets 2

plasma phosphocholine amount, post-diet [µM] PC_post 114779 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

biomarker quantification

various diets 2

plasma carnitine amount, baseline [µM] CARN_base 114781 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

biomarker quantification

various diets 2

plasma carnitine amount, post-diet [µM] CARN_post 114783 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

biomarker quantification

various diets 2

plasma glycerophosphocholine amount, post-diet [µM] GPC_post 114785 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

hormone quantification

various diets 2

plasma insulin amount, baseline [ng/mL] INS_base 114787 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

hormone quantification

various diets 2

plasma insulin amount, post-diet [ng/mL] INS_post 114789 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

hormone quantification

various diets 2

plasma glucose to insulin ratio, baseline [ratio] GLU_INS_base 114791 diet: HP group HFHS group

CC

22

f

8-11wks

N=5

2021

Bennett4

hormone quantification

various diets 2

plasma glucose to insulin ratio, post-diet [ratio] GLU_INS_post 114793 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

metabolic panel

various diets 2

metabolic health score, baseline [score] health_base 114795 diet: HP group HFHS group

CC

22

f

8-11wks

N=4

2021

Bennett4

metabolic panel

various diets 2

metabolic health score, post-diet [score] health_post 114797 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption accounting for body weight, day [mL/kg/h] VO2_bw_day 114799 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption accounting for body weight, night [mL/kg/h] VO2_bw_night 114801 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption accounting for body weight, average for day and night [mL/kg/h] VO2_bw_ave 114803 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption accounting for lean mass, day [mL/kg/h] VO2_lean_day 114805 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption accounting for lean mass, night [mL/kg/h] VO2_lean_night 114807 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption accounting for lean mass, average for day and night [mL/kg/h] VO2_lean_ave 114809 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption, day [mL/h] VO2_day 114811 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption, night [mL/h] VO2_night 114813 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

oxygen consumption, average for day and night [mL/h] VO2_ave 114815 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production accounting for body weight, day [mL/kg/h] VCO2_bw_day 114817 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production accounting for body weight, night [mL/kg/h] VCO2_bw_night 114819 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production accounting for body weight, average for day and night [mL/kg/h] VCO2_bw_ave 114821 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production accounting for lean mass, day [mL/kg/h] VCO2_lean_day 114823 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production accounting for lean mass, night [mL/kg/h] VCO2_lean_night 114825 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production accounting for lean mass, average for day and night [mL/kg/h] VCO2_lean_ave 114827 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production, day [mL/h] VCO2_day 114829 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production, night [mL/h] VCO2_night 114831 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

carbon dioxide production, average for day and night [mL/h] VCO2_ave 114833 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

respiratory exchange ratio (VCO2/O2), day [ratio] RER_day 114835 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

respiratory exchange ratio (VCO2/O2), night [ratio] RER_night 114837 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

respiratory exchange ratio (VCO2/O2), average for day and night [ratio] RER_ave 114839 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure accounting for body weight, day [kcal/h/kg] heat_bw_day 114841 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure accounting for body weight, night [kcal/h/kg] heat_bw_night 114843 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure accounting for body weight, average for day and night [kcal/h/kg] heat_bw_ave 114845 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure accounting for lean mass, day [kcal/h/kg] heat_lean_day 114847 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure accounting for lean mass, night [kcal/h/kg] heat_lean_night 114849 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure accounting for lean mass, average for day and night [kcal/h/kg] heat_lean_ave 114851 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure, day [kcal/h] heat_day 114853 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure, night [kcal/h] heat_night 114855 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

heat expenditure, average for day and night [kcal/h] heat_ave 114857 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis (beam breaks), day [n] XY_day 114859 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis (beam breaks), night [n] XY_night 114861 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis (beam breaks), average for day and night [n] XY_ave 114863 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis total (beam breaks), day [n] X_day 114865 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis total (beam breaks), night [n] X_night 114867 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis total (beam breaks), average for day and night [n] X_ave 114869 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis ambulatory movement (beam breaks), day [n] X_amb_day 114871 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis ambulatory movement (beam breaks), night [n] X_amb_night 114873 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis ambulatory movement (beam breaks), average for day and night [n] X_amb_ave 114875 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis fine movement (beam breaks), day [n] X_fine_day 114877 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis fine movement (beam breaks), night [n] X_fine_night 114879 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis fine movement (beam breaks), average for day and night [n] X_fine_ave 114881 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis total (beam breaks), day [n] Y_day 114883 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis total (beam breaks), night [n] Y_night 114885 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis total (beam breaks), average for day and night [n] Y_ave 114887 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis ambulatory movement (beam breaks), day [n] Y_amb_day 114889 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis ambulatory movement (beam breaks), night [n] Y_amb_night 114891 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis ambulatory movement (beam breaks), average for day and night [n] Y_amb_ave 114893 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis fine movement (beam breaks), day [n] Y_fine_day 114895 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis fine movement (beam breaks), night [n] Y_fine_night 114897 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on y-axis fine movement (beam breaks), average for day and night [n] Y_fine_ave 114899 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on z-axis rearing movement (beam breaks), day [n] Z_day 114901 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on z-axis rearing movement (beam breaks), night [n] Z_night 114903 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on z-axis rearing movement (beam breaks), average for day and night [n] Z_ave 114905 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

feed consumed, day [g] feed_day 114907 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

feed consumed, night [g] feed_night 114909 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

feed consumed, average for day and night [g] feed_ave 114911 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

energy intake, day [kcal] energy_day 114913 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

energy intake, night [kcal] energy_night 114915 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

energy intake, average for day and night [kcal] energy_ave 114917 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

protein intake, day [g] prot_day 114919 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

protein intake, night [g] prot_night 114921 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

protein intake, average for day and night [g] prot_ave 114923 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

fat intake, day [g] fat_day 114925 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

fat intake, night [g] fat_night 114927 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

fat intake, average for day and night [g] fat_ave 114929 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

carbohydrate intake, day [g] carb_day 114931 diet: HP group HFHS group:

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

carbohydrate intake, night [g] carb_night 114933 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

carbohydrate intake, average for day and night [g] carb_ave 114935 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis plus z-axis (beam breaks), day [n] XYZ_day 114937 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis plus z-axis (beam breaks), night [n] XYZ_night 114939 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis plus z-axis (beam breaks), average for day and night [n] XYZ_ave 114941 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

feed consumed per hour, day [g/h] feed_hr_day 114943 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

feed consumed per hour, night [g/h] feed_hr_night 114945 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

feed consumed per hour, average for day and night [g/h] feed_hr_ave 114947 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

energy intake per hour, day [kcal/h] energy_hr_day 114949 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

energy intake per hour, night [kcal/h] energy_hr_night 114951 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

intake monitoring

various diets 2

energy intake per hour, average for day and night [kcal/h] energy_hr_ave 114953 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis plus z-axis (beam breaks) per hour, day [n/h] XYZ_hr_day 114955 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis plus z-axis (beam breaks) per hour, night [n/h] XYZ_hr_night 114957 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Bennett4

monitoring system

various diets 2

activity on x-axis plus y-axis plus z-axis (beam breaks) per hour, average for day and night [n/h] XYZ_hr_ave 114959 diet: HP group HFHS group

CC

22

f

17-20wks

N=4

2021

Brinkmeyer1

body weight

Theiler's murine encephalomyelitis virus

body weight, post infection [g] bw 64401 day 0 day 2 day 4 day 6 day 8 day 10 day 14 day 17 day 22 day 27 (6 more)...

CC

5

both

4wks

N=5

2017

Brinkmeyer1

health assessment

Theiler's murine encephalomyelitis virus

clinical score (0=normal, 6=moribund), post infection [score] clin_score 64417 day 0 day 2 day 4 day 6 day 8 day 12 day 18 day 24 day 29 day 34 (6 more)...

CC

5

both

4wks

N=5

2017

Brinkmeyer1

RNA expression profiling

Theiler's murine encephalomyelitis virus

TMEV transcript abundance (normalized), post infection TMEV 64433 day 7 day 28

CC

4

both

4wks

N=1

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of seconds spent grooming, 10 min test, post infection wk 3 (manual assessment) [s] grooming 64435

CC

5

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of times mouse reared, 10 min test, post infection wk 3 (manual assessment) [n] activity_rearing 64436

CC

5

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

horizontal movement latency, 30 min test, post infection wk 3 [s] horiz_latency 64437 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of horizontal movements (beam breaks), 30 min test, post infection wk 3 [n] horiz_activity 64439 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

horizontal distance traveled, 30 min test, post infection wk 3 [cm] horiz_distance 64441 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent moving horizontally, 30 min test, post infection wk 3 [s] horiz_time 64443 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

horizontal movement velocity, 30 min test, post infection wk 3 [cm/s] horiz_velocity 64445 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of vertical plane entries, 30 min test, post infection wk 3 [n] vert_activity 64447 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of vertical plane episodes, 30 min test, post infection wk 3 [n] vert_episodes 64449 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent vertical, 30 min test, post infection wk 3 [s] vert_time 64451 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent resting, 30 min test, post infection wk 3 [s] resting 64453 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

number of center entries, 30 min test, post infection wk 3 [n] center_entries 64455 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent in center, 30 min test, post infection wk 3 [s] center_time 64457 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

open field test

Theiler's murine encephalomyelitis virus

time spent in periphery, 30 min test, post infection wk 3 [s] periphery_time 64459 trial 1 trial 2

CC

4

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

number of steps included in analysis as measured by DigiGait, post infection day 27, forelimb [n] num_steps_fore 64461 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

number of steps included in analysis as measured by DigiGait, post infection day 27, hindlimb [n] num_steps_hind 64463 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of swing phase (no paw contact with belt) as measured by DigiGait, post infection day 27, forelimb [s] swing_dur_fore 64465 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of swing phase (no paw contact with belt) as measured by DigiGait, post infection day 27, hindlimb [s] swing_dur_hind 64467 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in air as measured by DigiGait, post infection day 27, forelimb [%] swing_stride_fore 64469 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in air as measured by DigiGait, post infection day 27, hindlimb [%] swing_stride_hind 64471 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of braking phase as measured by DigiGait, post infection day 27, forelimb [s] brake_dur_fore 64473 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of braking phase as measured by DigiGait, post infection day 27, hindlimb [s] brake_dur_hind 64475 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in braking phase as measured by DigiGait, post infection day 27, forelimb [%] brake_stride_fore 64477 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in braking phase as measured by DigiGait, post infection day 27, hindlimb [%] brake_stride_hind 64479 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of stance phase that paw is in braking phase as measured by DigiGait, post infection day 27, forelimb [%] brake_stance_fore 64481 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of stance phase that paw is in braking phase as measured by DigiGait, post infection day 27, hindlimb [%] brake_stance_hind 64483 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of propulsion phase as measured by DigiGait, post infection day 27, forelimb [s] propel_dur_fore 64485 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of propulsion phase as measured by DigiGait, post infection day 27, hindlimb [s] propel_dur_hind 64487 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in propulsion phase as measured by DigiGait, post infection day 27, forelimb [%] propel_stride_fore 64489 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in propulsion phase as measured by DigiGait, post infection day 27, hindlimb [%] propel_stride_hind 64491 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of stance phase that paw is in propulsion phase as measured by DigiGait, post infection day 27, forelimb [%] propel_stance_fore 64493 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of stance phase that paw is in propulsion phase as measured by DigiGait, post infection day 27, hindlimb [%] propel_stance_hind 64495 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in any contact with treadmill belt as measured by DigiGait, post infection day 27, forelimb [%] stance_stride_fore 64497 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

percentage of total stride duration that paw is in any contact with treadmill belt as measured by DigiGait, post infection day 27, hindlimb [%] stance_stride_hind 64499 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of swing phase time to stance phase time as measured by DigiGait, post infection day 27, forelimb [ratio] stance_swing_fore 64501 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of swing phase time to stance phase time as measured by DigiGait, post infection day 27, hindlimb [ratio] stance_swing_hind 64503 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of one complete stride for one paw (equal to stance and swing durations) as measured by DigiGait, post infection day 27, forelimb [s] stride_dur_fore 64505 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

duration of one complete stride for one paw (equal to stance and swing durations) as measured by DigiGait, post infection day 27, hindlimb [s] stride_dur_hind 64507 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

number of times each second (cadence) that a paw takes a complete stride as measured by DigiGait, post infection day 27, forelimb [n/s] stride_freq_fore 64509 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

number of times each second (cadence) that a paw takes a complete stride as measured by DigiGait, post infection day 27, hindlimb [n/s] stride_freq_hind 64511 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

spatial length that a paw traverses through a given stride as measured by DigiGait, post infection day 27, forelimb [cm] stride_length_fore 64513 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

spatial length that a paw traverses through a given stride as measured by DigiGait, post infection day 27, hindlimb [cm] stride_length_hind 64515 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride length variability as measured by DigiGait, post infection day 27, forelimb [cm] stride_length_var_fore 64517 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride length variability as measured by DigiGait, post infection day 27, hindlimb [cm] stride_length_var_hind 64519 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride length coefficient of variation as measured by DigiGait, post infection day 27, forelimb [%] stride_length_CV_fore 64521 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride length coefficient of variation as measured by DigiGait, post infection day 27, hindlimb [%] stride_length_CV_hind 64523 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

angle that paw makes with long axis of direction of motion of mouse as measured by DigiGait, post infection day 27, forelimb [deg] paw_angle_fore 64525 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

angle that paw makes with long axis of direction of motion of mouse as measured by DigiGait, post infection day 27, hindlimb [deg] paw_angle_hind 64527 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

standard deviation of paw angle for set of strides recorded as measured by DigiGait, post infection day 27, forelimb [deg] paw_angle_SD_fore 64529 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

standard deviation of paw angle for set of strides recorded as measured by DigiGait, post infection day 27, hindlimb [deg] paw_angle_SD_hind 64531 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal paw area as measured by DigiGait, post infection day 27, forelimb [cm²] paw_area_max_fore 64533 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal paw area as measured by DigiGait, post infection day 27, hindlimb [cm²] paw_area_max_hind 64535 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

standard deviation of paw area for set of strides recorded as measured by DigiGait, post infection day 27, forelimb [cm²] paw_area_SD_fore 64537 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

standard deviation of paw area for set of strides recorded as measured by DigiGait, post infection day 27, hindlimb [cm²] paw_area_SD_hind 64539 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of forelimb stepping to fore limb stepping frequency (coordination metric) as measured by DigiGait, post infection day 27, forelimb [ratio] gait_symmetry_fore 64541 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of forelimb stepping to hind limb stepping frequency (coordination metric) as measured by DigiGait, post infection day 27, hindlimb [ratio] gait_symmetry_hind 64543 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_break_fore 64545 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during braking phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_break_hind 64547 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, forelimb [cm²/s] max_area_propuls_fore 64549 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

maximal rate of change in paw area in contact with treadmill belt during propulsion phase as measured by DigiGait, post infection day 27, hindlimb [cm²/s] max_area_propuls_hind 64551 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

overlap extent of ipsilateral fore and hind paws as measured by DigiGait, post infection day 27, forelimb [cm] overlap_distance_fore 64553 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

overlap extent of ipsilateral fore and hind paws as measured by DigiGait, post infection day 27, hindlimb [cm] overlap_distance_hind 64555 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

extent of overlap between ipsilateral fore and hind paws during full stance (balance metric) as measured by DigiGait, post infection day 27, forelimb [cm] paw_placement_fore 64557 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

extent of overlap between ipsilateral fore and hind paws during full stance (balance metric) as measured by DigiGait, post infection day 27, hindlimb [cm] paw_placement_hind 64559 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

gait variability metric as measured by DigiGait, post infection day 27, forelimb ataxia_coefficient_fore 64561 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

gait variability metric as measured by DigiGait, post infection day 27, hindlimb ataxia_coefficient_hind 64563 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

distance between centroid of a paw at peak stance and a reference line drawn through transverse midline of mouse (kinetics metric) as measured by DigiGait, post infection day 27, forelimb [cm] midline_distance_fore 64565 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

distance between centroid of a paw at peak stance and a reference line drawn through transverse midline of mouse (kinetics metric) as measured by DigiGait, post infection day 27, hindlimb [cm] midline_distance_hind 64567 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

distance between centroid of a paw at peak stance and a reference line drawn through axis of mouse (kinetics metric) as measured by DigiGait, post infection day 27, forelimb [cm] axis_distance_fore 64569 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

distance between centroid of a paw at peak stance and a reference line drawn through axis of mouse (kinetics metric) as measured by DigiGait, post infection day 27, hindlimb [cm] axis_distance_hind 64571 left right

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

perpendicular distance between centroids of either set of axial paws during peak stance as measured by DigiGait, post infection day 27 [cm] stance_width 64573 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stance width coefficient of variation as measured by DigiGait, post infection day 27 [%] stance_width_CV 64575 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

ratio of left and right stance durations as measured by DigiGait, post infection day 27 [ratio] stance_factor 64577 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

stride width variability as measured by DigiGait, post infection day 27 [cm] stride_width_var 64579 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

angle made between left and right paws as a function of stride length and stance width as measured by DigiGait, post infection day 27 [deg] step_angle 64581 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

step angle variability (standard deviation of step angle for set of strides recorded) as measured by DigiGait, post infection day 27 [deg] step_angle_SD 64583 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

step angle coefficient of variation as measured by DigiGait, post infection day 27 [%] step_angle_CV 64585 forelimb hindlimb

CC

4

both

4wks

N=1

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

length of forelimb steps as measured by foot print analysis, post infection [cm] length_fore 64587 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

width of forelimb steps as measured by foot print analysis, post infection [cm] width_fore 64594 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

length of hindlimb steps as measured by foot print analysis, post infection [cm] length_hind 64601 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

gait analysis

Theiler's murine encephalomyelitis virus

width of hindlimb steps as measured by foot print analysis, post infection [cm] width_hind 64608 wk 7 wk 8 wk 9 wk 10 wk 11 wk 12 wk 13

CC

5

both

4wks

N=2

2017

Brinkmeyer1

rotarod

Theiler's murine encephalomyelitis virus

time to fall from accelerating rotarod, post infection wk 7 [s] rotarod 64615 trial 1 trial 2 trial 3 trial 4 trial 5 trial 6 trial 7 trial 8 trial 9

CC

5

both

4wks

N=2

2017

CSNA03

open field test

(none)

total distance traveled, 60 min test (OFT), CC [cm] dist_OFT_cc 90002

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in perimeter and corners, 60 min test (OFT), CC [cm] dist_perimeter_corners_OFT_cc 90005

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in perimeter, 60 min test (OFT), CC [cm] dist_perimeter_OFT_cc 90008

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in corners, 60 min test (OFT), CC [cm] dist_corners_OFT_cc 90011

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in center, 60 min test (OFT), CC [%] pct_dist_center_OFT_cc 90014

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled slope, 60 min test (OFT), CC dist_slope_OFT_cc 90017

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

habituation ratio (first:last intervals), 60 min test (OFT), CC [ratio] habituation_OFT_cc 90056

CC w/par

59

both

4-19wks

N=15

2018

CSNA03

open field test

(none)

time in perimeter and corners, 60 min test (OFT), CC [s] time_perimeter_corners_OFT_cc 90101

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in perimeter, 60 min test (OFT), CC [s] time_perimeter_OFT_cc 90104

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in corners, 60 min test (OFT), CC [s] time_corner_OFT_cc 90107

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in center, 60 min test (OFT), CC [%] pct_center_time_OFT_cc 90110

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter and corners, 60 min test (OFT), CC [%] pct_dist_perimeter_corners_OFT_cc 90113

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter, 60 min test (OFT), CC [%] pct_dist_perimeter_OFT_cc 90116

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter and corners, 60 min test (OFT), CC [%] pct_time_perimeter_corner_OFT_cc 90119

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter, 60 min test (OFT), CC [%] pct_time_perimeter_OFT_cc 90122

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in center, 60 min test (OFT), CC [s] center_time_OFT_cc 90125

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in center, 60 min test (OFT), CC [cm] center_dist_OFT_cc 90128

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total distance traveled, 20 min test (LD box), CC [cm] dist_LD_cc 90131

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

distance traveled in light, 20 min test (LD box), CC [cm] dist_light_LD_cc 90134

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

distance traveled in dark, 20 min test (LD box), CC [cm] dist_dark_LD_cc 90137

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of total distance traveled in light, 20 min test (LD box), CC [%] pct_dist_light_LD_cc 90140

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total ambulatory time, 20 min test (LD box), CC [s] amb_time_tot_LD_cc 90143

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory time in light, 20 min test (LD box), CC [s] amb_time_light_LD_cc 90146

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory time in dark, 20 min test (LD box), CC [s] amb_time_dark_LD_cc 90149

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time spent ambulatory in light, 20 min test (LD box), CC [%] pct_amb_time_light_LD_cc 90152

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time resting in light, 20 min test (LD box), CC [%] pct_rest_time_light_LD_cc 90164

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total time, 20 min test (LD box), CC [s] time_tot_LD_cc 90203

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

time in light, 20 min test (LD box), CC [s] time_light_LD_cc 90206

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

time in dark, 20 min test (LD box), CC [s] time_dark_LD_cc 90209

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time in light, 20 min test (LD box), CC [%] pct_time_light_LD_cc 90212

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total ambulatory counts, 20 min test (LD box), CC [n] amb_counts_tot_LD_cc 90215

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory counts in light, 20 min test (LD box), CC [n] amb_counts_light_LD_cc 90218

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory counts in dark, 20 min test (LD box), CC [n] amb_counts_dark_LD_cc 90221

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of ambulatory counts in light, 20 min test (LD box), CC [%] pct_amb_counts_light_LD_cc 90224

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total number of light-dark transitions, 20 min test (LD box), CC [n] light_dark_transitions_LD_cc 90263

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

total number of entries (hole board), CC [n] entries_total_HB_cc 90266

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

number of novel entries (hole board), CC [n] entries_novel_HB_cc 90269

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

number of repeat entries (hole board), CC [n] entries_repeat_HB_cc 90272

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, excluding center gray zone (novelty preference), CC [%] time_wo_gray_cc 90287

CC w/par

59

both

6-14wks

N=17

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, including center gray zone (novelty preference), CC [%] time_w_gray_cc 90290

CC w/par

59

both

6-14wks

N=17

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, CC [cm] dist_d3_d2_cont_cc 90305

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d3_d2_cocaine_cc 90308

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, CC [cm] dist_d5_d3_cont_cc 90311

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, CC [cm] dist_d5_d3_cocaine_cc 90314

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, CC [cm] dist_d12_d2_cont_cc 90317

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d12_d2_cocaine_cc 90320

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, CC [cm] dist_d19_d11_cont_cc 90323

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, CC [cm] dist_d19_d11_cocaine_cc 90326

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, CC dist_d3_d11_auc_cont_cc 90438

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, CC dist_d3_d11_auc_cocaine_cc 90441

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, CC [cm] dist_f30_cont_cc 90329 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC [cm] dist_l60_cocaine_cc 90386 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

operant conditioning chamber

(none)

exit reason (intravenous self administration), CC de_exit_reason_cc 110389 categorical informational

CC w/par

56

both

4-25wks

N=5

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC [n] acquisition_cc 110390

CC w/par

53

both

4-25wks

N=4

2018

CSNA03

operant conditioning chamber

cocaine

dose response, number of infusions (intravenous self administration), CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

CC w/par

57

both

4-25wks

N=6

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_JAX 113851

CC w/par

52

both

N=3

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

latency (reversal learning assay), CC latency_cc_JAX 110501 informational acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

retrieval (reversal learning assay), CC retrieval_cc_JAX 110505 informational acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_Binghamton 113854

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

in vitro assay

(none)

peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, CC [h] period_cc 112544

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, CC [n] phase_cc 112545

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC [n/s] amplitude_cc 112546

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, CC [days] damping_cc 112547

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, CC [%] goodness_of_fit_cc 112548

CC w/par

40

both

8-12wks

N=4

2020

JaxCC1

open field test

(none)

whole arena time spent mobile, 20 min test [s] time_mobile_OF 89001

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

whole arena resting time, 20 min test [s] whole_rest_OF 89002

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

whole arena time spent vertical, 20 min test [s] time_vertical_OF 89003

CC

17

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

number of rears, 20 min test [n] rears_OF 89004 1st 5min 2nd 5min 3rd 5min 4th 5min

CC

17

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

total number of rears, 20 min test [n] rears_total_OF 89008

CC

17

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled [cm] distance_OF 89009 1st 5min 2nd 5min 3rd 5min 4th 5min

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

total distance traveled, 20 min test [cm] distance_total_OF 89013

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled habituation ratio, 20 min test [ratio] distance_habit__OF 89014

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled slope, 20 min test distance_slope_OF 89015

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled in center of arena, 20 min test [cm] center_dist_OF 89016

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

distance traveled in periphery of arena, 20 min test [cm] periphery_dist_OF 89017

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

average speed in center of arena, 20 min test [cm/s] center_speed_OF 89018

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

average speed in periphery of arena, 20 min test [cm/s] periphery_speed_OF 89019

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

whole arena average speed, 20 min test [cm/s] whole_speed_OF 89020

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

number of fecal boli, 20 min test [n] defecation_OF 89025

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

permanence time in periphery of arena, 20 min test [s] periphery_perm_OF 89028

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

permanence time in corners of arena, 20 min test [s] corners_perm_OF 89030

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in corners of arena, 20 min test [s] pct_corners_OF 89031

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in corners, habituation ratio, 20 min test [%] pct_corners_habit_OF 89032

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in corners, slope, 20 min test pct_corners_slope_OF 89033

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

permanence time in center of arena, 20 min test [s] center_perm_OF 89036

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in center of arena, 20 min test [%] pct_center_OF 89038

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in center, habituation ratio, 20 min test [ratio] pct_center_habit_OF 89039

CC

18

both

7-9wks

N=7

2018

JaxCC1

open field test

(none)

percentage of total time in center of arena, slope, 20 min test pct_center_slope_OF 89040

CC

18

both

7-9wks

N=7

2018

JaxCC1

body weight

(none)

body weight [g] bw_abr 89046

CC

18

both

15-17wks

N=3

2017

JaxCC1

ABR test

(none)

auditory brainstem response (ABR) threshold, sound pressure level [dB] pip 89047 6kHz pip 12kHz pip 18kHz pip 24kHz pip 30kHz pip

CC

18

both

15-17wks

N=3

2017

JaxCC1

hole board test

(none)

number of hole pokes, 20 min test [n] hole_pokes 89056

CC

7

both

8-9wks

N=5

2017

JaxCC1

acoustic startle test

(none)

average acoustic startle response (ASR) evoked by background noise [amplitude] ASR_BN 89061

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

average acoustic startle response (ASR), adjusted for background noise [amplitude] ASR 89062 sound pressure level: 74dB 78dB 82dB 120dB

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

average percent prepulse inhibition (PPI) evoked by 120 dB, adjusted for background noise [%] PPI 89071 prepulse stimulus: 74dB 78dB 82dB

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

average percent prepulse inhibition (PPI) evoked by global prepulse stimulus (74, 78, 82 dB), adjusted for background noise [%] PPI_global 89076

CC

18

both

9-11wks

N=7

2017

JaxCC1

acoustic startle test

(none)

maximum slope for percent prepulse inhibition (PPI) averages (74, 78, 82 dB), adjusted for background noise PPI_slope 89078

CC

18

both

9-11wks

N=7

2017

JaxCC1

light-dark box

(none)

latency to enter dark zone, 20 min test [s] reaction_time_LD 89086

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

time mobile in light zone, 20 min test [s] light_mobile_LD 89087

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

time mobile in dark zone, 20 min test [s] dark_mobile_LD 89088

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

time spent in light zone, 20 min test [s] light_dur_LD 89089

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

time spent in dark zone, 20 min test [s] dark_dur_LD 89090

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

percentage of total time in light zone, 20 min test [%] pct_light_LD 89091

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

percentage of total time in dark zone, 20 min test [%] pct_dark_LD 89092

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

number of transitions between light and dark zones, 20 min test [n] transitions_LD 89093

CC

18

both

8-10wks

N=7

2017

JaxCC1

light-dark box

(none)

fecal boli count, 20 min test [n] defecation_LD 89094

CC

18

both

8-10wks

N=7

2017

JaxCC1

body weight

(none)

body weight [g] bw_griptest 89095

CC

18

both

7-9wks

N=7

2017

JaxCC1

grip strength

(none)

forelimb grip strength [g] front_paws 89096 trial1 trial2 trial3

CC

18

both

7-9wks

N=7

2017

JaxCC1

grip strength

(none)

forelimb grip strength [g] front_paws_summ 89099 average average normalized to bw

CC

18

both

7-9wks

N=7

2017

JaxCC1

grip strength

(none)

forelimb and hindlimb grip strength [g] all_paws 89106 trial1 trial2 trial3

CC

18

both

7-9wks

N=7

2017

JaxCC1

grip strength

(none)

forelimb and hindlimb grip strength [g] all_paws_summ 89109 average average normalized to bw

CC

18

both

7-9wks

N=7

2017

JaxCC1

ECG

(none)

heart rate (beats per min) [n/min] HR 89113

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

heart rate variability, mean of differences between sequential beats (beats per min) [n/min] HR_V 89114

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

heart rate coefficient of variation (signal intensity) [%] HR_CV 89115

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of RR interval [ms] RR 89116

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of PQ interval [ms] PQ 89117

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of PR interval [ms] PR 89118

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of QRS interval [ms] QRS 89119

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of QT interval [ms] QT 89120

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of ST interval [ms] ST 89121

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

duration of QTC interval, calculated by dividing QT interval by square root of preceding RR interval [ms] QTc 89122

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

QT dispersion, measured as inter-lead variability of QT intervals [ms] QT_dispersion 89123

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

QTc dispersion, calculated as rate-corrected QT dispersion [ms] QTc_dispersion 89124

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

mean SR amplitude, mean amplitude of signal measured from signal minimum line to peak of QRS [mV] SR_amplitude 89125

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

mean R amplitude, mean amplitude of signal measured from isoelectric line to peak of QRS [mV] R_amplitude 89126

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

root mean square of successive differences of neighboring RR intervals [ms] rMSSD 89127

CC

18

both

10-12wks

N=7

2017

JaxCC1

ECG

(none)

proportion of number of pairs of successive beat-to-beat intervals that exceed 50 ms (6>ms) [%] pNN50 89128

CC

18

both

10-12wks

N=2

2017

JaxCC1

tail suspension test

(none)

latency to immobility, 5 min test [s] immob_latency_TS 89134

CC

14

both

10-12wks

N=7

2018

JaxCC1

tail suspension test

(none)

duration of immobility, 5 min test [s] immob_duration_TS 89135

CC

14

both

10-12wks

N=7

2018

JaxCC1

rotarod

(none)

duration [s] duration 89139

CC

18

both

10-12wks

N=7

2018

JaxCC1

rotarod

(none)

mean duration on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] duration_rota 89141

CC

18

both

10-12wks

N=7

2018

JaxCC1

rotarod

(none)

learning difference on accelerating rotarod (4-40 rpm/5 min) over 5 trials [s] learn_diff_rota 89142

CC

18

both

10-12wks

N=7

2018

JaxCC1

rotarod

(none)

learning slope on accelerating rotarod (4-40 rpm/5 min) over 5 trials learn_slope_rota 89143

CC

18

both

10-12wks

N=7

2018

JaxCC1

urinalysis

(none)

glucose (urine GLU) [mg/dL] urine_GLU 89151

CC

14

both

12-13wks

N=5

2017

JaxCC1

urinalysis

(none)

magnesium level (urine Mg) [mg/dL] urine_Mg 89152

CC

13

both

12-13wks

N=5

2017

JaxCC1

urinalysis

(none)

creatinine (urine CREA) [mg/dL] CREA 89153

CC

14

both

12-13wks

N=5

2017

JaxCC1

urinalysis

(none)

microalbumin (urine MA), calculated [mg/dL] MA 89154

CC

14

both

12-13wks

N=5

2017

JaxCC1

urinalysis

(none)

albumin-creatinine ratio (urine ACR) [mg/g] ACR 89155

CC

14

both

12-13wks

N=5

2017

JaxCC1

DXA

(none)

percent fat, whole body scan, head excluded [%] pct_fat 89160

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

fat tissue mass, head excluded [g] fat 89161

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

fat tissue mass to body weight ratio [ratio] fat_adj 89162

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

lean tissue mass of whole body scan, head excluded [g] lean 89163

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

lean tissue mass to body weight ratio [ratio] lean_adj 89164

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

total tissue mass, whole body scan, head excluded [g] TTM 89165

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

bone mineral content of whole body scan, head excluded [g] BMC 89169

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

bone mineral content to body weight ratio [ratio] BMC_adj 89170

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

bone mineral density of whole body scan, head excluded [g/cm²] BMD 89171

CC

18

both

13-15wks

N=7

2017

JaxCC1

DXA

(none)

bone area, whole body, head excluded [cm²] bone_area 89172

CC

18

both

13-15wks

N=7

2017

JaxCC1

body size and weight

(none)

body weight [g] bw_dxa 89173

CC

18

both

13-15wks

N=7

2017

JaxCC1

body size and weight

(none)

body length [cm] body_length 89174

CC

18

both

13-15wks

N=7

2017

JaxCC1

metabolic panel

(none)

total bilirubin (plasma TBIL) [mg/dL] TBIL 89179

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

calcium (plasma Ca) [mg/dL] calcium 89180

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

chloride (plasma Cl) [mmol/L] chloride 89181

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

iron (plasma Fe) [mg/dL] iron 89182

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

phosphorus (plasma phosphate) [mg/dL] phosphate 89183

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

potassium (plasma K) [mmol/L] potassium 89184

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

alkaline phosphatase (plasma ALP) [IU/L] ALP 89185

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

sodium (plasma Na) [mmol/L] sodium 89186

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

alanine transaminase (plasma ALT) [IU/L] ALT 89187

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

aspartate transaminase (plasma AST) [IU/L] AST 89188

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

aspartate transaminase to alanine transaminase ratio (plasma AST:ALT) [ratio] AST_ALT_ratio 89189

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

carbon dioxide (plasma CO₂) [mmol/L] carbon_dioxide 89190

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

glucose (plasma GLU, no fast) [mg/dL] GLU 89191

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

albumin (plasma Alb) [g/L] albumin 89192

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

total protein (plasma TP) [g/L] total_protein 89194

CC

18

both

17-19wks

N=6

2017

JaxCC1

metabolic panel

(none)

blood urea nitrogen (BUN) [mg/dL] urea 89195

CC

18

both

17-19wks

N=5

2017

JaxCC1

lipid profile

(none)

HDL cholesterol (plasma HDL) [mg/dL] HDL 89196

CC

18

both

17-19wks

N=6

2017

JaxCC1

lipid profile

(none)

HDL cholesterol to total cholesterol ratio [ratio] HDL_total_ratio 89197

CC

18

both

17-19wks

N=6

2017

JaxCC1

lipid profile

(none)

total cholesterol (plasma CHOL, no fast) [mg/dL] CHOL 89198

CC

18

both

17-19wks

N=6

2017

JaxCC1

lipid profile

(none)

non-esterified fatty acids (plasma NEFA) [mmol/L] NEFA 89199

CC

18

both

17-19wks

N=5

2017

JaxCC1

lipid profile

(none)

triglyceride (plasma TG, no fast) [mg/dL] TG 89200

CC

18

both

17-19wks

N=6

2017

JaxCC1

hormone quantification

(none)

insulin (plasma) [pg/mL] insulin 89201

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

red blood cell count (RBC; per volume x 10⁶) [n/µL] RBC 89206

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

reticulocyte count (Retic; units per volume x 10⁹) [n/µL] Retic 89207

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

reticulocyte differential (percent of total RBC) [%] pct_Retic 89208

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

white blood cell count (WBC; units per volume x 10³) [n/µL] WBC 89209

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

basophil differential (percent of total WBC) [%] pct_BASO 89210

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

eosinophil differential (percent of total WBC) [%] pct_EOS 89211

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

lymphocyte differential (percent of total WBC) [%] pct_LYM 89212

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

monocyte differential (percent of total WBC) [%] pct_MONO 89213

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

neutrophil differential (percent of total WBC) [%] pct_NEUT 89214

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

large unstained cells (percent of total WBC) [%] pct_LUC 89215

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

hematocrit (HCT) [%] HCT 89219

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

measured hemoglobin (mHGB) [g/dL] mHGB 89220

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

calculated hemoglobin (cHGB) [g/dL] cHGB 89221

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

RBC corpuscular hemoglobin concentration mean (CHCM) [g/dL] CHCM 89222

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean corpuscular hemoglobin (CHr) [pg] CHr 89223

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

hemoglobin concentration distribution width (HDW) [g/dL] HDW 89224

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean RBC corpuscular hemoglobin (MCH) [pg] MCH 89225

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean RBC corpuscular hemoglobin concentration (MCHC) [g/dL] MCHC 89226

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

RBC corpuscular distribution width (RDW) [%] RDW 89229

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean RBC corpuscular volume (MCV) [fL] MCV 89230

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

platelet count (PLT; units per volume x 10³) [n/µL] PLT 89231

CC

18

both

17-19wks

N=6

2017

JaxCC1

complete blood count

(none)

mean platelet volume (MPV) [fL] MPV 89232

CC

18

both

17-19wks

N=6

2017

JaxCC1

body weight

(none)

body weight [g] bw 89236

CC

18

both

17-19wks

N=6

2017

JaxCC1

organ weights

(none)

heart weight [mg] heart_wt 89237 weight normalized to body weight

CC

18

both

17-19wks

N=6

2017

Lazear1

organ weights

(none)

testis weight (1 testis) [g] testis_wt 63101

CC

12

m

15-22wks

N=2

2018

Lazear1

sperm count

(none)

number of sperm per mL of semen (x 10⁶) [n/mL] sperm_count 63102

CC

10

m

15-22wks

N=2

2018

Lazear1

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 63103

CC

10

m

15-22wks

N=2

2018

Lazear1

microscopy

(none)

percentage of sperm that move in a consistent direction [%] sperm_processive 63104

CC

10

m

15-22wks

N=2

2018

Lazear1

colony observation

(none)

mean litter size after mating with two FVB/NJ females [n] litter_size 63105

CC

10

m

15-22wks

N=1

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD3- [%] CD3_neg 63501

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic CD3- lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_CD3_neg 63502

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are NK cells (CD49+ CD19-) [%] NK_cells_of_tot 63503

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27- CD11b- [%] CD27_neg_CD11b_neg 63504

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27+ CD11b- [%] CD27_pos_CD11b_neg 63505

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27+ CD11b+ [%] CD27_pos_CD11b_pos 63506

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are CD27- CD11b+ [%] CD27_neg_CD11b_pos 63507

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK cells that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_NK 63508

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are pre-mNK (B220+ CD11c+) [%] pre_mNK_of_tot 63509

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are NK T cells (TCRb+ CD1d+) [%] NKT_cells 63510

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_NKT 63511

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4+ NK T cells [%] CD4_pos_CD8_neg_NKT_of_tot 63512

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic NK T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_NKT 63513

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4- CD8- NK T cells [%] CD4_neg_CD8_neg_NKT_of_tot 63514

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are T cells [%] T_cells 63515

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_Tcells 63516

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_CD8_neg_of_tot 63517

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4- CD8+ [%] CD4_neg_CD8_pos_of_Tcells 63518

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD8+ T cells [%] CD4_neg_CD8_pos_of_tot 63519

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_Tcells 63520

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic lymphocytes that are CD4- CD8- T cells [%] CD4_neg_CD8_neg_of_tot 63521

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

ratio of splenic CD4+ to CD8+ T cells [ratio] CD4_CD8_ratio 63522

CC w/par

76

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are plasmacytoid dendritic cells [%] pDC 63523

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are conventional dendritic cells [%] cDC 63524

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are merocytic [%] mDC_of_cDC 63525

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are merocytic dendritic cells [%] mDC_of_tot 63526

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are cDC1 [%] cDC1_of_cDC 63527

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are cDC1 conventional dendritic cells [%] cDC1_of_tot 63528

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic conventional dendritic cells that are cDC2 [%] cDC2_of_cDC 63529

CC w/par

74

both

5-8wks

N=2

2018

Lesage1

immune cell quantification

(none)

percentage of splenic leukocytes that are cDC2 conventional dendritic cells [%] cDC2_of_tot 63530

CC w/par

74

both

5-8wks

N=2

2018

Mao1

body weight

(none)

body weight [g] bw 54101

CC

16

both

10wks

N=11

2015

Mao1

rotarod

(none)

speed prior to falling off of accelerating rotarod, 20 rpm/min [n/min] speed 54111

CC

16

both

10wks

N=11

2015

McMullan1

colony observation

(none)

age (local parameter) [mo] age_mo 60401

CC

50

f

17-72wks

N=5

2017

McMullan1

body size and weight

(none)

body weight [g] body_wt 60411

CC

50

f

17-72wks

N=5

2017

McMullan1

MRI

(none)

weight of fat portion of body mass, whole body with head [g] fat_wt 60421

CC

50

f

17-72wks

N=5

2017

McMullan1

MRI

(none)

percentage of body mass that is fat, whole body with head [%] fat_pct 60422

CC

50

f

17-72wks

N=5

2017

McMullan1

MRI

(none)

weight of lean portion of body mass, whole body with head [g] lean_wt 60423

CC

50

f

17-72wks

N=5

2017

McMullan1

MRI

(none)

percentage of body mass that is lean, whole body with head [%] lean_pct 60424

CC

50

f

17-72wks

N=5

2017

McMullan1

treadmill endurance test

(none)

total forced endurance distance [m] endurance 60431

CC

50

f

7-72wks

N=5

2017

McMullan2

running wheel monitoring

(none)

total distance [m] distance 60501 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...

CC

43

f

20-88wks

N=4

2017

McMullan2

running wheel monitoring

(none)

total duration [min] duration 60531 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...

CC

43

f

20-88wks

N=4

2017

McMullan2

running wheel monitoring

(none)

mean speed [m/min] speed 60561 day: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 (11 more)...

CC

43

f

20-88wks

N=4

2017

McMullan3

colony observation

(none)

age (local parameter) [mo] age_mo 60601

CC

43

f

20-88wks

N=4

2017

McMullan3

body weight

(none)

body weight [g] body_wt 60611 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

percentage of body mass that is fat [%] fat 60621 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

percentage of body mass that is lean [%] lean 60631 start 2 wks 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

body weight

(none)

body weight response [%] body_wt_start 60641 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

fat mass response [%] fat_start 60651 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

MRI

(none)

lean mass response [%] lean_start 60661 start to 2 wks 2 wks to 4 wks start to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan3

intake monitoring

(none)

food intake [g] food_start 60671 start to 2 wks 2 wks to 4 wks

CC

43

f

20-88wks

N=4

2017

McMullan4

body weight

(none)

body weight at start of experiment [g] bw_start 61301 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

body weight

exercise

body weight after 2 wks of treatment [g] bw_end 61306 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

body weight

exercise

body weight, response after 2 wks of treatment [%] bw_resp 61311 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

(none)

percentage of body mass that is fat at start of experiment [%] fat_start 61316 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

exercise

percentage of body mass that is fat after 2 wks of treatment [%] fat_end 61321 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

exercise

percentage of body mass that is fat, response after 2 wks of treatment [%] fat_resp 61326 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

(none)

percentage of body mass that is lean at start of experiment [%] lean_start 61331 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

exercise

percentage of body mass that is lean after 2 wks of treatment [%] lean_end 61336 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

MRI

exercise

percentage of body mass that is lean, response after 2 wks of treatment [%] lean_resp 61341 control group wheel access

CC

13

f

32-40wks

N=6

2018

McMullan4

running wheel monitoring

exercise

mean total daily distance for days 11-12 of wheel access [km] distance 61346

CC

13

f

32-40wks

N=7

2018

McMullan4

running wheel monitoring

exercise

mean total daily duration for days 11-12 of wheel access [min] duration 61351

CC

13

f

32-40wks

N=7

2018

McMullan4

running wheel monitoring

exercise

mean daily speed for days 11-12 of wheel access [m/min] speed 61356

CC

13

f

32-40wks

N=7

2018

McMullan4

intake monitoring

exercise

total food intake over 2 wks of wheel access [g] food 61361

CC

13

f

32-40wks

N=7

2018

McMullan4

intake monitoring

exercise

total food intake over 2 wks of wheel access adjusted to bw_start [ratio] food_adj 61366

CC

13

f

32-40wks

N=7

2018

McMullan6

body weight

(none)

body weight at start of experiment [g] bw_start 61501 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

body weight

exercise

body weight at after 4 wks of treatment [g] bw_end 61506 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

body weight

exercise

body weight, response to 4 wks of treatment [%] bw_resp 61511 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

(none)

percentage of body mass that is fat at start of experiment [%] fat_start 61516 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

exercise

percentage of body mass that is fat after 4 wks of treatment [%] fat_end 61521 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

exercise

percentage of body mass that is fat, response after 4 wks of treatment [%] fat_resp 61526 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

(none)

percentage of body mass that is lean at start of experiment [%] lean_start 61531 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

exercise

percentage of body mass that is lean after 4 wks of treatment [%] lean_end 61536 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan6

MRI

exercise

percentage of body mass that is lean, response after 4 wks of treatment [%] lean_resp 61541 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean oxygen consumption at start of experiment, during day [mL/h] VO2_d_start 61601 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean oxygen consumption after 4 wks of treatment, during day [mL/h] VO2_d_end 61604 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean oxygen consumption at start of experiment, during night [mL/h] VO2_n_start 61607 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean oxygen consumption after 4 wks of treatment, during night [mL/h] VO2_n_end 61611 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean carbon dioxide production at start of experiment, during day [mL/h] VCO2_d_start 61614 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean carbon dioxide production after 4 wks of treatment, during day [mL/h] VCO2_d_end 61617 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean carbon dioxide production at start of experiment, during night [mL/h] VCO2_n_start 61621 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean carbon dioxide production after 4 wks of treatment, during night [mL/h] VCO2_n_end 61624 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean respiratory exchange rate at start of experiment, during day [ratio] RER_d_start 61627 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean respiratory exchange rate after 4 wks of treatment, during day [ratio] RER_d_end 61631 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean respiratory exchange rate at start of experiment, during night [ratio] RER_n_start 61634 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean respiratory exchange rate after 4 wks of treatment, during night [ratio] RER_n_end 61637 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

activity (beam breaks) at start of experiment, during day [n] act_d_start 61641 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

activity (beam breaks) after 4 wks of treatment, during day [n] act_d_end 61644 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

activity (beam breaks) at start of experiment, during night [n] act_n_start 61647 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

activity (beam breaks) after 4 wks of treatment, during night [n] act_n_end 61651 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean heat production at start of experiment, during day [kcal/h/kg] heat_d_start 61654 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean heat production after 4 wks of treatment, during day [kcal/h/kg] heat_d_end 61657 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

(none)

mean heat production at start of experiment, during night [kcal/h/kg] heat_n_start 61661 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

monitoring system

exercise

mean heat production after 4 wks of treatment, during night [kcal/h/kg] heat_n_end 61664 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

(none)

total food intake at start of experiment, during day [g] food_d_start 61667 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

exercise

total food intake after 4 wks of treatment, during day [g] food_d_end 61671 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

(none)

total food intake at start of experiment, during night [g] food_n_start 61674 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

exercise

total food intake after 4 wks of treatment, during night [g] food_n_end 61677 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

(none)

total water intake at start of experiment, during day [mL] water_d_start 61681 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

exercise

total water intake after 4 wks of treatment, during day [mL] water_d_end 61684 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

(none)

total water intake at start of experiment, during night [mL] water_n_start 61687 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

McMullan7

intake monitoring

exercise

total water intake after 4 wks of treatment, during night [mL] water_n_end 61691 no exercise group moderate intensity group high intensity group

CC

4

both

8-10wks

N=8

2018

Molenhuis1

monitoring system

(none)

social interaction (time exploring unfamiliar conspecific mouse), 2 min interval [s] social_time 110068

CC

52

m

7-20wks

N=5

2018

Molenhuis1

monitoring system

(none)

social discrimination capacity (preference for novel versus familiar conspecific mouse) [ratio] discrimination 110069 short term discrimination long term discrimination

CC

49

m

7-20wks

N=4

2018

Molenhuis1

monitoring system

(none)

distance traveled with four novel objects, 10 min test [cm] distance 110071

CC

52

m

7-20wks

N=6

2018

Molenhuis1

monitoring system

(none)

time spent digging with four novel objects, 10 min test [s] digging 110072

CC

52

m

7-20wks

N=5

2018

Molenhuis1

monitoring system

(none)

time spent grooming with four novel objects, 10 min test [s] grooming 110073

CC

52

m

7-20wks

N=5

2018

Molenhuis1

body weight

(none)

body weight [g] bw 110074

CC

51

m

7-20wks

N=6

2018

Molenhuis1

organ weights

(none)

brain weight [g] brain_wt 110075

CC

52

m

7-20wks

N=5

2018

Shorter4

body weight

(none)

body weight [g] bw 110093

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

testis weight [g] testis 110094 left right

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

testis weight mean [g] testis_mean 110096

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

testis weight as a percentage of body weight [%] testis_pct_bw 110097

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

epididymis plus vas deferens weight [g] epidid_vd 110098 left right

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

epididymis plus vas deferens weight mean [g] epidid_vd_mean 110100

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

epididymis plus vas deferens weight as a percentage of body weight [%] epidid_vd_pct_bw 110101

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

seminal vesicles weight total [g] semin_vesi_tot 110102

CC

12

m

15-33wks

N=3

2019

Shorter4

organ weights

(none)

seminal vesicles weight as a percentage of body weight [%] semin_vesi_pct_bw 110103

CC

12

m

15-33wks

N=3

2019

Shorter4

sperm count

(none)

sperm count per mouse (x 10⁶) [n] sperm_count 110104

CC

12

m

15-33wks

N=3

2019

Shorter4

sperm count

(none)

sperm count per mg testis weight (x 10³) [n/mg] sperm_adj 110105

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

percentage of sperm that are motile [%] motile 110106 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] vigorous 110108 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] hyper 110110 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

microscopy

(none)

sperm mean curvilinear velocity [µm/s] VCL 110112 10 min 90 min

CC

12

m

15-33wks

N=3

2019

Shorter4

histopathology

(none)

percentage of sperm with normal morphology [%] normal_sperm 110114

CC

12

m

15-33wks

N=3

2019

Shorter4

histopathology

(none)

percentage of sperm with abnormal head shape [%] abnormal_head 110115

CC

12

m

15-33wks

N=3

2019

Shorter4

histopathology

(none)

percentage of sperm with abnormal tail bending [%] abnormal_tail 110116

CC

12

m

15-33wks

N=3

2019

Shorter4

histopathology

(none)

percentage of sperm with broken tails [%] broken_tail 110117

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of sperm that are motile [%] sperm_motile 65601 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'vigorous' [%] sperm_vigor 65606 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'progressive' [%] sperm_prog 65611 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'hyperactivated' [%] sperm_hyper 65616 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'intermediate' [%] sperm_int 65621 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'slow' [%] sperm_slow 65626 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

percentage of motile sperm that are 'weak' [%] sperm_weak 65631 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean path velocity [µm/s] sperm_VAP 65636 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean straight line velocity [µm/s] sperm_VSL 65641 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean curvilinear velocity [µm/s] sperm_VCL 65646 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean lateral head displacement (amplitude) [µm] sperm_ALH 65651 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean cross beat frequency [Hz] sperm_BCF 65656 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean straightness [ratio] sperm_STR 65661 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Shorter6

microscopy

(none)

sperm mean linearity [ratio] sperm_LIN 65666 10 min 30 min 60 min 90 min 120 min

CC

12

m

15-33wks

N=3

2019

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 1, core fucose with 1 GlcNAc antenna (relative abundance) [%] gp1 110006

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 2, composition not determined (relative abundance) [%] gp2 110007

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 3, composition not determined (relative abundance) [%] gp3 110008

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 4, core fucose with 2 GlcNAc antennae (relative abundance) [%] gp4 110009

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 5, composition not determined (relative abundance) [%] gp5 110010

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 6, core fucose with bisecting GlcNAc and 2 GlcNAc antennae (relative abundance) [%] gp6 110011

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 7, composition not determined (relative abundance) [%] gp7 110012

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 8, core fucose with 2 GlcNAc antennae, 1 galactose linked to alpha1,6-linked core mannose (relative abundance) [%] gp8 110013

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 9, core fucose with 2 GlcNAc antennae, 1 galactose linked to alpha1,3-linked core mannose (relative abundance) [%] gp9 110014

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 10, core fucose with bisecting GlcNAc and 2 GlcNAc antennae, 1 galactose linked to alpha1,6-linked core mannose (relative abundance) [%] gp10 110015

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 11, composition not determined (relative abundance) [%] gp11 110016

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 12, composition not determined (relative abundance) [%] gp12 110017

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 13, composition not determined (relative abundance) [%] gp13 110018

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 14, core fucose with 2 GlcNAc antennae, 2 galactoses (relative abundance) [%] gp14 110019

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 15, composition not determined (relative abundance) [%] gp15 110020

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 16, composition not determined (relative abundance) [%] gp16 110021

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 17a, core fucose with 2 GlcNAc antennae, 1 galactose linked to alpha1,6-linked core mannose, 1 sialic acid (relative abundance) [%] gp17a 110022

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 17b, core fucose with 2 GlcNAc antennae, 1 galactose linked to alpha1,3-linked core mannose, 1 sialic acid (relative abundance) [%] gp17b 110023

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 18, composition not determined (relative abundance) [%] gp18 110024

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 19, composition not determined (relative abundance) [%] gp19 110025

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 20, core fucose with 2 GlcNAc antennae, 2 galactoses, 1 sialic acid (relative abundance) [%] gp20 110026

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 21, composition not determined (relative abundance) [%] gp21 110027

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 22, composition not determined (relative abundance) [%] gp22 110028

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 23, core fucose with 2 GlcNAc antennae, 3 galactoses, 1 sialic acid (relative abundance) [%] gp23 110029

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 24, composition not determined (relative abundance) [%] gp24 110030

CC

111

both

4-140wks

N=3

2018

Zaytseva1

glycosylation profile

(none)

IgG glycan peak 25, core fucose with 2 GlcNAc antennae, 2 galactoses, 2 sialic acids (relative abundance) [%] gp25 110031

CC

111

both

4-140wks

N=3

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with bisected N-acetylglucosamine N-glycan structures (relative abundance) [%] mIgG1_B 110032

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with galactosylated N-glycan structures (relative abundance) [%] mIgG1_G 110033

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with agalactosylated N-glycan structures (relative abundance) [%] mIgG1_G0 110034

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with monogalactosylated N-glycan structures (relative abundance) [%] mIgG1_G1 110035

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with digalactosylated N-glycan structures (relative abundance) [%] mIgG1_G2 110036

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with sialylated N-glycan structures (relative abundance) [%] mIgG1_S 110037

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with monosialylated N-glycan structures (relative abundance) [%] mIgG1_S1 110038

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with disialylated N-glycan structures (relative abundance) [%] mIgG1_S2 110039

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG1 with alpha1,3-linked galactose residue N-glycan structures (relative abundance) [%] mIgG1_aGal 110040

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with bisected N-acetylglucosamine N-glycan structures (relative abundance) [%] mIgG2_B 110041

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with galactosylated N-glycan structures (relative abundance) [%] mIgG2_G 110042

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with agalactosylated N-glycan structures (relative abundance) [%] mIgG2_G0 110043

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with monogalactosylated N-glycan structures (relative abundance) [%] mIgG2_G1 110044

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with digalactosylated N-glycan structures (relative abundance) [%] mIgG2_G2 110045

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with sialylated N-glycan structures (relative abundance) [%] mIgG2_S 110046

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with monosialylated N-glycan structures (relative abundance) [%] mIgG2_S1 110047

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with disialylated N-glycan structures (relative abundance) [%] mIgG2_S2 110048

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG2 with alpha1,3-linked galactose residue N-glycan structures (relative abundance) [%] mIgG2_aGal 110049

CC

94

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with bisected N-acetylglucosamine N-glycan structures (relative abundance) [%] mIgG3_B 110050

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with galactosylated N-glycan structures (relative abundance) [%] mIgG3_G 110051

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with agalactosylated N-glycan structures (relative abundance) [%] mIgG3_G0 110052

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with monogalactosylated N-glycan structures (relative abundance) [%] mIgG3_G1 110053

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with digalactosylated N-glycan structures (relative abundance) [%] mIgG3_G2 110054

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with sialylated N-glycan structures (relative abundance) [%] mIgG3_S 110055

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with monosialylated N-glycan structures (relative abundance) [%] mIgG3_S1 110056

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with disialylated N-glycan structures (relative abundance) [%] mIgG3_S2 110057

CC

95

both

20-117wks

N=2

2018

Zaytseva2

glycosylation profile

(none)

IgG3 with alpha1,3-linked galactose residue N-glycan structures (relative abundance) [%] mIgG3_aGal 110058

CC

95

both

20-117wks

N=2

2018

Filter Table Results